InflaRx News

InflaRx Buy Rating Backed by Promising Drug Prospects and Financial Stability

TipRanksAug 13 21:59

Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Krystal Biotech (KRYS) and InflaRx (IFRX)

TipRanksAug 12 20:37

InflaRx Buy Rating Affirmed: Financial Stability and Gohibic's Market Potential

TipRanksAug 9 00:29

HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target

BenzingaJun 25 01:32

InflaRx Analyst Ratings

BenzingaJun 25 01:32

InflaRx Analyst Ratings

BenzingaJun 6 19:10

InflaRx's Promising Future: Buy Rating Reaffirmed Amidst Pipeline Progress and Upcoming R&D Insights

TipRanksMay 10 13:35

InflaRx Analyst Ratings

BenzingaMay 9 18:55

HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target

BenzingaMay 9 18:55

InflaRx Buy Rating: Strong Financials and High Potential of Gohibic for PG Treatment

TipRanksMay 9 18:35

LifeSci Capital Remains a Hold on InflaRx (IFRX)

TipRanksMay 9 04:50

LifeSci Capital Reaffirms Their Hold Rating on InflaRx (IFRX)

TipRanksMar 23 03:10

InflaRx Analyst Ratings

BenzingaMar 22 20:25

Buy Rating Justified for InflaRx Despite Earnings Miss: Financial Stability and INF904's Market Potential

TipRanksMar 22 18:25

InflaRx Analyst Ratings

BenzingaJan 26 00:23

Analysts Offer Insights on Healthcare Companies: Walgreens Boots Alliance (WBA), InflaRx (IFRX) and Eli Lilly & Co (LLY)

TipRanksJan 9 14:30

InflaRx's Promising INF904 Phase 1 Results Prompt Buy Rating

TipRanksJan 5 19:28

InflaRx (IFRX) Gets a Hold From LifeSci Capital

TipRanksJan 5 05:35

Buy Rating for InflaRx: Potential Breakthrough PG Treatment and Promising Revenue Forecasts

TipRanksNov 6, 2023 23:16

Analysts Have Conflicting Sentiments on These Healthcare Companies: InflaRx (IFRX), Exelixis (EXEL) and Humana (HUM)

TipRanksNov 6, 2023 14:50